Sumitomo Mitsui Trust Group’s Tandem Diabetes Care TNDM Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,700	Closed	-$442K	–	1210
2021 Q3	$442K	Sell	3,700 -2,700	-42%	-$297K	﹤0.01%	1108
2021 Q2	$623K	Buy	+6,400	New	+$571K	﹤0.01%	1093
2021 Q1	–	Sell	-3,076	Closed	-$294K	–	1171
2020 Q4	$294K	Sell	3,076 -11,026	-78%	-$1.14M	﹤0.01%	1095
2020 Q3	$1.6M	Sell	14,102 -4,436	-24%	-$466K	﹤0.01%	915
2020 Q2	$1.83M	Buy	18,538 +6	+0%	+$479	﹤0.01%	891
2020 Q1	$1.19M	Sell	18,532 -6,703	-27%	-$470K	﹤0.01%	921
2019 Q4	$1.5M	Buy	25,235 +20,257	+407%	+$1.25M	﹤0.01%	919
2019 Q3	$294K	Sell	4,978 -1,293	-21%	-$82.5K	﹤0.01%	1038
2019 Q2	$405K	Buy	+6,271	New	+$405K	﹤0.01%	956

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Sumitomo Mitsui Trust Group's TNDM Position: Q4 2021 in Review

Sumitomo Mitsui Trust Group sold out of Tandem Diabetes Care (TNDM) in Q4 2021, closing a stake of 3,700 shares — an estimated $442K sold.

Sumitomo Mitsui Trust Group first reported a position in TNDM in Q2 2019 and held it in 9 quarters. The position peaked at $1.83M in Q2 2020. 388 funds tracked by Wall St. Rank hold TNDM as of Q4 2021.

Sumitomo Mitsui Trust Group reported no remaining Tandem Diabetes Care position as of Q4 2021 after selling out during the quarter.
Sumitomo Mitsui Trust Group sold 3,700 Tandem Diabetes Care shares in Q4 2021, an estimated $442K.
Sumitomo Mitsui Trust Group first reported a position in Tandem Diabetes Care in Q2 2019 and held it in 9 quarters.
Sumitomo Mitsui Trust Group's Tandem Diabetes Care position peaked at $1.83M in Q2 2020.
388 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2021.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q4 2021, filed 2 Feb 2022.